Placebo Control
JULY 31, 2013
If a sponsor gets approval from FDA to delay reporting (as is routine for all drugs that are either not approved for any indication, or being studied for a new indication – i.e., the overwhelming majority of pharma drug trials ), but doesn't post that approval on the registry, the JCO authors deem that trial “noncompliant”.
Pharmaceutical Technology
JUNE 15, 2023
Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. Food and Drug Administration approval.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
AUGUST 9, 2021
HCPs don’t necessarily want pharma trying to sell products via social media. The best approach is to use social media to connect HCPs to clincial information and drug trials. A leading pharma company recently sponsored a series of Q&A around the use of their new cancer drug.
pharmaphorum
FEBRUARY 4, 2022
The first project between Bayer and Aalto got underway in June 2021, and focused on using technology to make it easier for patients to participate in drug trials. Along with remote monitoring of patients to reduce clinic visits, it is also looking at using AI to improve the safety and efficiency of the clinical drug research.
pharmaphorum
SEPTEMBER 27, 2021
In 2020, 53 novel medicines were approved by the FDA and of the patients who took part in trials, just 8% were black and 6% were Asian. This is not a box-ticking exercise and in some ways it’s as much about cultural intelligence as cultural diversity.
Expert insights. Personalized for you.
40 
Let's personalize your content